| Serial Number | 86227226 |
| Word Mark | SURE-NAC |
| Filing Date | Thursday, March 20, 2014 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 7, 2015 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 5, 2014 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating inflammatory conditions; Bio-metallic compounds for use in the manufacture of pharmaceutical preparations; Chemical additives for use in the manufacture of anti-inflammatory agent; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Excipients for use in the manufacture of anti-inflammatory; Glycerine for use in the manufacture of pharmaceuticals; Glycerol for use in the manufacture of medicine; Phenothiazine for use as a pharmaceutical intermediate; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; the foregoing goods containing N-acetylcysteine |
| Goods and Services | Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; the foregoing goods containing N-acetylcysteine |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 3, 2014 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 3, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tiara Pharmaceuticals |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Los Altos, CA 94022 |
| Party Name | Tiara Pharmaceuticals |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Altos, CA 94022 |
| Event Date | Event Description |
| Tuesday, September 8, 2015 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, September 7, 2015 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, February 3, 2015 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, December 19, 2014 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Thursday, August 21, 2014 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, August 5, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 5, 2014 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 16, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 30, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, June 30, 2014 | ASSIGNED TO LIE |
| Thursday, June 12, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 12, 2014 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, June 12, 2014 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 12, 2014 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 12, 2014 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 10, 2014 | ASSIGNED TO EXAMINER |
| Thursday, April 3, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, March 24, 2014 | NEW APPLICATION ENTERED IN TRAM |